Lyra Therapeutics (LYRA)
(Delayed Data from NSDQ)
$0.32 USD
0.00 (1.41%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $0.32 0.00 (1.27%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.23 |
EPS Last Quarter | -0.29 |
Last EPS Surprise | 14.71% |
ABR | 2.83 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.33 |
Next Year | -0.65 |
EPS (TTM) | -1.13 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.40M | 0.42M | 1.67M | 1.01M |
# of Estimates | 2 | 2 | 3 | 2 |
High Estimate | 0.60M | 0.60M | 2.33M | 1.59M |
Low Estimate | 0.20M | 0.24M | 1.10M | 0.43M |
Year ago Sales | 0.54M | 0.15M | 1.56M | 1.67M |
Year over Year Growth Est. | -25.93% | 180.00% | 6.93% | -39.38% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.23 | -0.20 | -1.33 | -0.65 |
# of Estimates | 3 | 3 | 4 | 4 |
Most Recent Consensus | -0.22 | -0.21 | -1.42 | -0.79 |
High Estimate | -0.19 | -0.17 | -0.91 | -0.28 |
Low Estimate | -0.26 | -0.24 | -1.54 | -1.03 |
Year ago EPS | -0.27 | -0.22 | -1.23 | -1.33 |
Year over Year Growth Est. | 14.81% | 9.09% | -8.13% | 50.94% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 3 | 2 | 0 | 2 |
Up Last 60 Days | 3 | 2 | 0 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 3 | 1 |
Down Last 60 Days | 0 | 0 | 3 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.23 | -0.20 | -1.33 | -0.65 |
7 Days Ago | -0.23 | -0.20 | -1.33 | -0.65 |
30 Days Ago | -0.31 | -0.26 | -1.19 | -0.81 |
60 Days Ago | -0.31 | -0.26 | -1.15 | -0.81 |
90 Days Ago | -0.31 | -0.26 | -1.15 | -0.81 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.23 | -0.21 | -1.47 | -0.77 |
Zacks Consensus Estimate | -0.23 | -0.20 | -1.33 | -0.65 |
Earnings ESP | 0.00% | -2.50% | -10.49% | -18.97% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.29 | -0.35 | -0.22 | -0.27 | NA |
Estimate | -0.34 | -0.26 | -0.33 | -0.33 | NA |
Difference | 0.05 | -0.09 | 0.11 | 0.06 | 0.03 |
Surprise | 14.71% | -34.62% | 33.33% | 18.18% | 7.90% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more